A Slovenian company that makes an antioxidant pill some media have dubbed an “elixir of youth” is threatening to file lawsuits against scientists who have publicly spoken out against the product, calling it insufficiently tested. The face-off has an added bit of complexity: one prominent Croatian scientist is criticising another who has endorsed the therapy.
Full article in ScienceInsider
Science journalist, news editor at Research Professional News
Mićo Tatalović is a news editor at Research Professional News. He has previously worked as a science news editor at Nature, New Scientist, and SciDev.Net. In 2018, he completed the Knight Science Journalism Program at the Massachusetts Institute of Technology in Cambridge, US, where he researched the use of machine learning and artificial intelligence in science journalism. He is also immediate former chairman of the Association of British Science Writers, and a board member of the European Federation for Science Journalism.
He runs the section Balkan Science Beat.
He runs the section Balkan Science Beat.
Latest posts by Mićo Tatalović (see all)
- The science and ethics of turning octopuses into ‘lab rats’ - 24 February, 2022
- UK recorded more than 10,000 extra non-covid deaths since July: how do we know vaccines are not to blame? - 17 February, 2022
- Professor Balthazar’s biggest flops: how the cult 1960-70s Yugoslav animation series portrayed failure in science - 17 October, 2021
EuroScientist journal 